8-K - Picard Medical, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Picard Medical, Inc. issued a press release on March 19, 2026, announcing a patient in his twenties was supported by the SynCardia Total Artificial Heart for 119 days at UCSF Health before a successful heart transplant on March 14, 2026. This marks the second successful bridge-to-transplant case at UCSF using the device.

Key Takeaways

1Patient implanted with SynCardia Total Artificial Heart on November 15, 2025.

2Supported for 119 days before transplant on March 14, 2026.

3Second successful case at UCSF Health.

4Device is FDA and Health Canada approved with over 2,100 implants worldwide.

Current Report Details

Event Type

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

. Regulation FD Disclosure. On March 19, 2026, Picard Medical, Inc. (the “Company”) issued a press release announcing that a patient had been sustained by the S

Regulation Fd

9.01

. Financial Statements and Exhibits. (d) Exhibits The following exhibits are being furnished herewith: Exhibit No. Description 99.1 Picard Medical, Inc. Press R

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EXHIBIT 99.1